Castleman's disease in HIV-infected patients;Maladie de Castleman chez les patients infectés par le VIH

Revue de Medecine Interne

Volumn 23, Issue 2, 2002, Pages 155-163

  Aaron, L ^a   Lidove, O ^b   Viard, J P ^a   Troisvallet, D ^c   Piketty, C ^d   Vittecoq, D ^e   Zucman, D ^b   Bletry O ^b   Dupont, B ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b FOCH HOSPITAL   (France)

^c Hopital de Gonesse   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^e HÔPITAL PAUL BROUSSE   (France)

Author keywords

Castleman's disease; HIV; Human herpes virus 8; Interleukin 6; vIL 6

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; ETOPOSIDE; INTERLEUKIN 6; VINBLASTINE;

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; CLINICAL FEATURE; FEVER; HEPATOSPLENOMEGALY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHADENOPATHY; OPPORTUNISTIC INFECTION; PROGNOSIS; REVIEW;

EID: 0036173311     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(01)00531-8     Document Type: Short Survey

References (60)

1. Localized mediastinal lymph-node hyperplasia resembling thymoma
2. Lymph nod modification in patients with the acquired immunodeficiency syndrome (AIDS) or with AIDS related complex (ARC)
3. Multicentric Castleman's disease in HIV infection. A clinical and pathological study of 20 patients
4. Maladie de Castleman du sujet VIH sous trithérapie: Sept cas
5. Multicentric Castleman's disease in HIV infection therapy and HHV 8 viral load
6. Kaposi sarcoma associated herpes like virus (Human Herpes Virus 8) DNA sequences in multicentric Castleman's disease: Is there any relevant association in non-human immunodeficiency virus-infected patients?
7. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease
8. Antibodies to human herpesvirus 8 in the general population and in Kaposi's sarcoma patients
9. Kaposi's sarcoma herpesvirus-like DNA sequences in the saliva of individuals infected with human immunodeficiency virus
10. Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population
11. Resolution of membrano-proliferative glomerulonephritis complicating angiofollicular lymph node hyperplasia (Castleman's disease)
12. Castleman's disease and glomerular nephropathy (apropos of 1 case)
13. Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes: The POEMS syndrome: Report on two cases and a review of the literature
14. Plasmacellular Castleman's disease and POEMS syndrome
15. The Crow-Fukase syndrome: A study of 102 cases in Japan
16. Human herpes virus 8 infection in patients with POEMS syndrome-associated multicentric Castleman's disease
17. Concurrent multicentric angiofollicular lymph node hyperplasia and peripheral T-cell lymphoma
18. Molecular analysis of clonality in Castleman's disease
19. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas
20. Expression of human herpesvirus-8 onco- and cytokine homologues in an HIV seronegative patient with multicentric Castleman's disease and primary effusion lymphoma
21. Molecular genetic and immunohistochemical analyses of a case of multicentric Castleman's disease
22. Clonal rearrangement or immunoglobulin and T-cell receptor genes in systemic Castleman's disease. Associated with Epstein-Barr virus
23. An immunohistological and genotypic study of the plasma cell of form Castleman's disease
24. Multicentric Castleman's disease in association with a solitary plasmocytoma: A case report
25. Molecular genetic, cytogenetic, and immunophenotypic analyses in Castleman's disease of the plasma cell type
26. Biological and clinical aspects of interleukin 6
27. Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice
28. IgG1 plasmocytosis in interleukin 6 transgenic mice
29. Lymphoproliferative disorder and imbalanced T-helper response in C/EBP beta-deficient mice
30. Pathogenic significance of interleukin 6 (IL-6/ BSF-2) in Castleman's disease
31. Maladie de Castleman (hyperplasie lymphoïde angiofolliculaire): Polymorphisme clinique, biologique et évolutif
32. Immunodeficiency and IL-6 production by peripheral blood monocytes in multicentric Castleman's disease
33. Giant lymph node hyperplasia (Castleman's disease) with spontaneous production of high levels of B-cell differentiation factor activity
34. Expression of interleukin-6 in Castleman's disease
35. Interleukin-6 gene expression in Castleman's disease
36. Identification of herpes virus-like DNA sequences in AIDS-associated Kaposi's sarcoma
37. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients
38. The role of human herpes-virus 8 and Epstein-Barr virus in the pathogenesis of giant lymph node hyperplasia (Castleman's disease)
39. Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders
40. Tropism of human herpesvirus 8 for peripheral blood lymphocytes in patients with Castleman's disease
41. Human herpesvirus-8/Kaposi's sarcoma associated herpesvirus is a new transmissible virus that infect B cells
42. Herpes-like DNA sequences, AIDS related tumors and Castleman's disease
43. Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease
44. Expression of cell-homologous genes of human herpesvirus 8 in human immunodeficiency virus-negative lymphoproliferative diseases
45. Exacerbations of clinical symptoms in human immunodeficiency virus type 1-infected patients with multicentric Castleman's disease are associated with a high increase in Kaposi's sarcoma herpesvirus DNA load in peripheral blood mononuclear cells
46. High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C-reactive protein correlate with exacerbation of multicentric Castleman disease in HIV-infected patients
47. Transient angiolymphoid hyperplasia and Kaposi's sarcoma after primary infection with human herpesvirus 8 in a patient with human immunodeficiency virus infection
48. Human herpesvirus type 8 interleukin-6 homologue is functionally active on human myeloma cells
49. Expression of vascular endothelial growth factor in sera and lymph nodes of the plasma cell type of Castleman's disease
50. G-protein-coupled receptor of Kaposi's sarcoma associated herpesvirus is a viral oncogene and angiogenesis activator
51. Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease
52. Is interferonalpha is an active agent in Castleman's disease?
53. Successful treatment of multicentric Castleman's disease in a patient with human immunodeficiency virus infection
54. No effect of protease inhibitor on clinical and virological evolution of Castleman's disease in an HIV-1 infected patients
55. Aggressive angiofollicular lymph node hyperplasia (Castleman's disease) treated with high dose melphalan and autologous bone transplantation
56. 2-chloro-deoxyadenosine therapy for giant lymph node hyperplasia
57. Retinoid antagonism of NF-IL-6: Insight into the mechanism of antiproliferative effects of retinoids in Kaposi's sarcoma
58. Retinoic acid for treatment of multicentric Castleman's disease
59. Alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin 6 antibody
60. Multicentric giant follicular lymph node hyperplasia